Operating Income (Loss) in USD of Transphorm, Inc. from Q2 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Transphorm, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2017 to Q4 2023.
  • Transphorm, Inc. Operating Income (Loss) for the quarter ending 31 Dec 2023 was -$8.92M, a 9.87% increase year-over-year.
  • Transphorm, Inc. Operating Income (Loss) for the twelve months ending 31 Dec 2023 was -$30.5M, a 22.7% decline year-over-year.
  • Transphorm, Inc. annual Operating Income (Loss) for 2022 was -$28.8M, a 191% decline from 2021.
  • Transphorm, Inc. annual Operating Income (Loss) for 2021 was -$9.9M, a 26.1% increase from 2020.
  • Transphorm, Inc. annual Operating Income (Loss) for 2020 was -$13.4M, a 12.4% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Transphorm, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$30.5M -$8.92M +$977K +9.87% 01 Oct 2023 31 Dec 2023 10-Q 20 Feb 2024
Q3 2023 -$31.5M -$6.5M -$996K -18.1% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 -$30.5M -$6.78M -$1.75M -34.7% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 -$28.8M -$8.34M -$3.89M -87.1% 01 Jan 2023 31 Mar 2023 10-K 28 Jun 2023
Q4 2022 -$24.9M -$9.9M -$5.13M -108% 01 Oct 2022 31 Dec 2022 10-Q 20 Feb 2024
Q3 2022 -$19.8M -$5.5M -$9.44M -240% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$10.3M -$5.03M -$430K -9.34% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$9.9M -$4.46M +$81K +1.79% 01 Jan 2022 31 Mar 2022 10-K 28 Jun 2023
Q4 2021 -$9.98M -$4.77M -$321K -7.22% 01 Oct 2021 31 Dec 2021 10-Q 21 Feb 2023
Q3 2021 -$9.66M $3.93M +$8.35M 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$18M -$4.6M -$5.51M -611% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$12.5M -$4.54M +$892K +16.4% 01 Jan 2021 31 Mar 2021 10-K 29 Jun 2022
Q4 2020 -$13.4M -$4.45M -$7.09M -269% 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022
Q3 2020 -$6.31M -$4.42M +$94K +2.08% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$6.41M $901K +$5.79M 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$12.2M -$5.43M -$272K -5.27% 01 Jan 2020 31 Mar 2020 10-KT 24 Jun 2021
Q4 2019 -$11.9M $2.64M +$2.65M 01 Oct 2019 31 Dec 2019 10-KT 24 Jun 2021
Q3 2019 -$14.6M -$4.51M -$4.5M -43568% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$10.1M -$4.89M -$4.88M -69171% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 -$5.19M -$5.16M -$5.15M 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 -$34.7K -$10.3K +$10.6K +50.5% 01 Oct 2018 31 Dec 2018 10-Q 07 Feb 2019
Q3 2018 -$45.2K -$10.3K -$3.11K 01 Jul 2018 30 Sep 2018 10-Q 23 Jan 2020
Q2 2018 -$42.1K -$7.05K +$30.5K +81.2% 01 Apr 2018 30 Jun 2018 10-K 27 Sep 2019
Q1 2018 -$72.6K -$6.93K* 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 -$20.9K 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019
Q3 2017 -$7.23K* 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$37.5K 01 Jun 2017 30 Jun 2017 10-K 28 Sep 2018

Transphorm, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$28.8M -$18.9M -191% 01 Apr 2022 31 Mar 2023 10-K 28 Jun 2023
2021 -$9.9M +$3.5M +26.1% 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2023
2020 -$13.4M -$1.48M -12.4% 01 Jan 2020 31 Dec 2020 10-K 29 Jun 2022
2019 -$11.9M -$11.9M -28212% 01 Jan 2019 31 Dec 2019 10-KT 24 Jun 2021
2018 -$42.1K 01 Jul 2017 30 Jun 2018 10-K 27 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.